4//SEC Filing
Walker Luke Nathaniel 4
Accession 0001725160-25-000029
CIK 0001725160other
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 4:43 PM ET
Size
4.7 KB
Accession
0001725160-25-000029
Insider Transaction Report
Form 4
Walker Luke Nathaniel
Director
Transactions
- Purchase
Common Stock
2025-01-31$1.76/sh+14,200$24,966→ 86,681 total
Documents
Issuer
Zentalis Pharmaceuticals, Inc.
CIK 0001725160
Entity typeother
Related Parties
1- filerCIK 0001701440
Filing Metadata
- Form type
- 4
- Filed
- Feb 3, 7:00 PM ET
- Accepted
- Feb 4, 4:43 PM ET
- Size
- 4.7 KB